Risk factors for treatment failure in orthopedic device-related methicillin-resistant Staphylococcus aureus infection
- 415 Downloads
The purpose of this study was to determine the clinical and microbiological risk factors for treatment failure of methicillin-resistant Staphylococcus aureus (MRSA) orthopedic device-related infection (ODRI). A retrospective cohort study of patients with MRSA ODRI who were treated at Geneva University Hospitals between 2000 and 2008 was undertaken. Stored MRSA isolates were retrieved for genetic characterization and determination of the vancomycin minimum inhibitory concentration (MIC). Fifty-two patients were included, of whom 23 (44%) had joint arthroplasty and 29 (56%) had osteosynthesis. All 41 of the retrieved MRSA isolates were susceptible to vancomycin (MIC ≤ 2 mg/L) and 35 (85%) shared genetic characteristics of the South German clone (ST228). During a median follow-up of 391 days (range, 4–2,922 days), 18 patients (35%) experienced treatment failure involving MRSA persistence or recurrence. Microbiological factors such as infection with the predominant clone and a vancomycin MIC of 2 mg/L were not associated with treatment failure. Using a Cox proportional hazards model, implant retention (hazard ratio [HR], 4.9; 95% confidence interval [CI], 1.3–18.2; P = 0.017) and single-agent antimicrobial therapy (HR, 4.4; 95% CI, 1.2–16.3; P = 0.025) were independent predictors of treatment failure after debridement. Therapy using a combination of antimicrobials should be considered for patients with MRSA ODRI, especially when implant removal is not feasible.
KeywordsVancomycin Treatment Failure Fusidic Acid Prosthetic Joint Infection SCCmec Type
This work was supported by Fondation pour la Recherche Médicale, Paris, France. We are indebted to Elzbieta Huggler, Myriam Girard, Hélène Meugnier, Michele Bes, Colette Nicollier, Christine Courtier, Christine Cardon, Céline Spinelli, and Caroline Bouveron for the isolate characterization. We thank Nathalie Vallier for assistance with the statistical analysis, Abel Ferry for technical assistance, and David Young for editorial guidance.
- 16.Amaral MM, Coelho LR, Flores RP et al (2005) The predominant variant of the Brazilian epidemic clonal complex of methicillin-resistant Staphylococcus aureus has an enhanced ability to produce biofilm and to adhere to and invade airway epithelial cells. J Infect Dis 192:801–810CrossRefPubMedGoogle Scholar
- 19.Clinical and Laboratory Standards Institute (CLSI) (2007) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard M7-S17, Wayne, PAGoogle Scholar